Literature DB >> 18783952

The search for disease-associated compositional shifts in bowel bacterial communities of humans.

Gerald W Tannock1.   

Abstract

The bowels of humans contain resident bacterial communities, the members of which are numerous and biodiverse. Changes in the composition of bowel communities is accepted to occur in relation to antibiotic-associated colitis of the elderly, but compositional alterations could also be relevant to allergic diseases in children and inflammatory bowel diseases (i.e. Crohn's disease and ulcerative colitis). It is timely, therefore, to reflect on current knowledge of the bacterial community of the human bowel in relation to disease. Modern analytical methods provide tools by which compositional shifts in bacterial communities can be detected, but inadequate bowel-sampling procedures and poorly designed studies hamper progress. Moreover, demonstration that population shifts cause the disease and are not just reflections of a diseased state is necessary. Therefore, important challenges remain for bacteriologists in investigations of the bowel bacterial community in relation to disease.

Entities:  

Mesh:

Year:  2008        PMID: 18783952     DOI: 10.1016/j.tim.2008.07.005

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  12 in total

1.  Probiotics and Gastrointestinal Disease: Clinical Evidence and Basic Science.

Authors:  Elaine O Petrof
Journal:  Antiinflamm Antiallergy Agents Med Chem       Date:  2009-09-01

2.  Diet-induced metabolic improvements in a hamster model of hypercholesterolemia are strongly linked to alterations of the gut microbiota.

Authors:  Inés Martínez; Grant Wallace; Chaomei Zhang; Ryan Legge; Andrew K Benson; Timothy P Carr; Etsuko N Moriyama; Jens Walter
Journal:  Appl Environ Microbiol       Date:  2009-05-01       Impact factor: 4.792

3.  Dietary selenium affects host selenoproteome expression by influencing the gut microbiota.

Authors:  Marina V Kasaikina; Marina A Kravtsova; Byung Cheon Lee; Javier Seravalli; Daniel A Peterson; Jens Walter; Ryan Legge; Andrew K Benson; Dolph L Hatfield; Vadim N Gladyshev
Journal:  FASEB J       Date:  2011-04-14       Impact factor: 5.191

4.  The role of the immune system in regulating the microbiota.

Authors:  Benjamin P Willing; Navkiran Gill; B Brett Finlay
Journal:  Gut Microbes       Date:  2010-03-04

5.  Commensal Bacteroides species induce colitis in host-genotype-specific fashion in a mouse model of inflammatory bowel disease.

Authors:  Seth M Bloom; Vinieth N Bijanki; Gerardo M Nava; Lulu Sun; Nicole P Malvin; David L Donermeyer; W Michael Dunne; Paul M Allen; Thaddeus S Stappenbeck
Journal:  Cell Host Microbe       Date:  2011-05-19       Impact factor: 21.023

6.  Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis in Mice via a Toll-Like Receptor 4/p21-Activated Kinase 1 Cascade.

Authors:  Yaxin Wu; Jiao Wu; Ting Chen; Qing Li; Wei Peng; Huan Li; Xiaowei Tang; Xiangsheng Fu
Journal:  Dig Dis Sci       Date:  2018-03-05       Impact factor: 3.199

7.  Resistant starches types 2 and 4 have differential effects on the composition of the fecal microbiota in human subjects.

Authors:  Inés Martínez; Jaehyoung Kim; Patrick R Duffy; Vicki L Schlegel; Jens Walter
Journal:  PLoS One       Date:  2010-11-29       Impact factor: 3.240

Review 8.  Enteric pathogens through life stages.

Authors:  Glynis Kolling; Martin Wu; Richard L Guerrant
Journal:  Front Cell Infect Microbiol       Date:  2012-08-25       Impact factor: 5.293

9.  Clinical Use of Probiotics in Pediatric Allergy (CUPPA): A World Allergy Organization Position Paper.

Authors:  Alessandro Fiocchi; Wesley Burks; Sami L Bahna; Leonard Bielory; Robert J Boyle; Renata Cocco; Sten Dreborg; Richard Goodman; Mikael Kuitunen; Tari Haahtela; Ralf G Heine; Gideon Lack; David A Osborn; Hugh Sampson; Gerald W Tannock; Bee Wah Lee
Journal:  World Allergy Organ J       Date:  2012-11       Impact factor: 4.084

10.  Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack.

Authors:  Chamutal Gur; Yara Ibrahim; Batya Isaacson; Rachel Yamin; Jawad Abed; Moriya Gamliel; Jonatan Enk; Yotam Bar-On; Noah Stanietsky-Kaynan; Shunit Coppenhagen-Glazer; Noam Shussman; Gideon Almogy; Angelica Cuapio; Erhard Hofer; Dror Mevorach; Adi Tabib; Rona Ortenberg; Gal Markel; Karmela Miklić; Stipan Jonjic; Caitlin A Brennan; Wendy S Garrett; Gilad Bachrach; Ofer Mandelboim
Journal:  Immunity       Date:  2015-02-10       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.